Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children

Clinical trial NCT00000773 · COMPLETED

Trial details

NCT number: NCT00000773
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumonia, Pneumocystis Carinii HIV Infections

Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.